Xconomy National

Archives

by in

Entry	Author	Date	Location
Immune Design Rakes In Another $11M From Prior VC Round	Luke Timmerman	10/05/11	Seattle
Merck Joins the Big Pharma VC Party, Setting Up $250M Biotech Investment Fund	Luke Timmerman	09/15/11	National
Bristol Diabetes Drug Gets Thumbs-Down	Arlene Weintraub	07/20/11	New York
Optivia Biotech Finds its Way to Profits, With a Little Help from Friends at the FDA	Luke Timmerman	07/05/11	San Francisco
PTC Teams With AstraZeneca	Arlene Weintraub	06/29/11	New York
Bristol Churns Out Diabetes Data	Arlene Weintraub	06/27/11	New York
Report: AstraZeneca to Lay Off 135 in MA	Gregory T. Huang	05/19/11	Boston
Should Biology Go Open Source? Join the Debate June 16 With Phil Sharp and Stephen Friend	Luke Timmerman	05/18/11	Boston
Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A	Luke Timmerman	05/17/11	Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu	Arlene Weintraub	04/28/11	New York
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO	Luke Timmerman	04/27/11	Seattle
Open Source Biology Deserves a Shot	Luke Timmerman	04/11/11	National
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News	Luke Timmerman	03/31/11	Seattle
Sage Starts Takeda, CHDI Work	Luke Timmerman	03/30/11	Seattle
Testing Experimental Drugs in Combination – A New Trend	Troy Wilson	12/22/10	San Diego
How To Keep Academic/Big Pharma Alliances from Going off the Rails	Scott Forrest	11/30/10	San Diego
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine	Luke Timmerman	11/30/10	Detroit
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News	Erin Kutz	11/19/10	Boston
Pfizer Academic Program HQ in Cambridge	Erin Kutz	11/16/10	Boston
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit	Ryan McBride	11/12/10	Boston
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan	Luke Timmerman	11/10/10	Seattle
Big Fish Help Out the Smaller Fish in the Life Sciences Pond	Sylvia Pagán Westphal	11/09/10	National
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News	Erin Kutz	10/29/10	Boston
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights	Ryan McBride	10/28/10	Boston
Omeros Nabs $25M from Paul Allen and the State, Immune Design Strikes 1st Big Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	10/28/10	Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster	Luke Timmerman	10/26/10	Seattle
Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner	Ryan McBride	10/21/10	Detroit
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis	Luke Timmerman	10/20/10	San Diego
Necessity is the Mother of Stratification: Personalized Medicine is Getting Real	Don Rule	09/30/10	Seattle
Rigel Nabs $25M From AstraZeneca	Luke Timmerman	09/29/10	San Francisco
Page 1 of 3	next page »